Injectable codeine is accessible for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this may end up in nonimmune mast-cell degranulation and resulting anaphylactoid reaction. Codeine suppositories are marketed in certain international locations. Expanded Access is a possible pathway for the affected individual with a significant or promptly https://cornstalkm445eqf3.blogsvirals.com/profile